Aicuris Gmbh + Co. Kg.

Bayer Schering Pharma Ag

Bayer Healthcare Aktiengesellschaft

Aicuris Anti-infective Cures Gmbh

Aic246 Ag & Co. Kg

Susanne Nikolic

Rolf Grosser

Kerstin Henninger

Holger Zimmermann

Guy Hewlett

Dieter Lang

Peter Nell

Tobias Wunberg

Mario Jeske

Judith Baumeister

Rudolf Schohe-Loop

Thomas Lampe

Jörg Keldenich

Ulrich Betz

Frank Suessmeier

Joerg Keldenich

Frank Süβmeier

Tse-I Lin

Jürgen Reefschläger

Gerald Kleymann

Thomas Krämer

Frank Süssmeier

Juergen Reefschlaeger

Thomas Kraemer

Frank Süßmeier

The invention relates to substituted dihydroquinazolines and to processes for their preparation and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular for use as antiviral agents, in particular against cytomegalo viruses.

Substituted dihydroquinazolines

The invention relates to heterocyclyl-substituted dihydroquinazolines of formula (I), to processes for their preparation, to medicaments containing them, and to methods for the treatment and/or prophylaxis of diseases, in particular, for use as anti-viral agents, in particular, against cytomegaloviruses.

Heterocyclyl-substituted dihydroquinazolines and their use as antiviral agents

The invention relates to substituted dihydroquinazolines and to a method for the production thereof, the use thereof for treating and/or preventing diseases and for producing drugs for treating and/or preventing diseases, in particular for the use of the inventive dihydroquinazolines in the form of antiviral agents, in particular against cytomegaloviruses.

Substituted dihydroquinazolines II

The invention relates to dihydroquinazolines and methods for the production thereof, the use thereof in the treatment and/or prophylaxis of diseases, in addition to the use thereof in the production of medicaments in the treatment and/or prophylaxis of diseases, especially for use as anti-viral agents, especially against cytomegalo viruses.

2-(3-phenyl-2-piperazinyl-3,4-dihydroquinazolin-4-yl)acetic acids as antiviral agents, especially against cytomegaloviruses

The invention relates to substituted quinazolines and to methods for the production thereof, in addition to the use thereof in the production of medicaments for the treatment and/or prophylaxis of diseases, especially for use as antiviral agents, especially against cytomegaloviruses.

Substituted quinazolines as antiviral agents, especially against cytomegaloviruses

Growing community of inventors

Monheim, Germany

Susanne Nikolic